We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Bronchial Carcinoma Treated by Adjuvant Cancer Chemotherapy

Thomas W. Shields, MD; C. Denis Robinette, PhD; Robert J. Keehn, MS
Arch Surg. 1974;109(2):329-333. doi:10.1001/archsurg.1974.01360020189037.
Text Size: A A A
Published online


Four prospective randomized trials were undertaken to evaluate single-drug chemotherapy after resection of bronchial carcinoma in men. The drugs studied were mechlorethamine hydrochloride, cyclophosphamide, and methotrexate. A total of 2,348 curative resections were carried out; 1,172 patients received adjuvant therapy after the resection and 1,176 underwent operation alone. The accumulated five- and ten-year survival rates were 24.8% and 13.5%, respectively, for the treatment group and 26.2% and 16.3% for the control group. The differences were not significant. It is therefore apparent that single-drug adjuvant therapy is not beneficial in the management of patients who have undergone a curative resection of a bronchial carcinoma. Involvement of lymph nodes in the specimen was associated with a significantly poorer prognosis, but cell type, other than oat cell, appeared not to affect the prognosis when a curative resection had been carried out.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.